New Two-Pronged drug tested for rare thymus cancers

This study is testing an experimental drug called bintrafusp alfa (M7824) for people with thymoma or thymic carcinoma that has returned or worsened after standard platinum-based chemotherapy. The drug is designed to work in two ways: by blocking a protein that helps tumors hide from the immune system and by inhibiting a growth factor in the tumor environment. Participants receive the drug by IV infusion every two weeks to see if it can shrink tumors and control the disease.